

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 8.87501998 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 7.94848732 |
| 3 | triglyceride catabolic process (GO:0019433) | 7.35227602 |
| 4 | white fat cell differentiation (GO:0050872) | 7.24797248 |
| 5 | brown fat cell differentiation (GO:0050873) | 7.06522509 |
| 6 | biotin metabolic process (GO:0006768) | 6.60743702 |
| 7 | acylglycerol catabolic process (GO:0046464) | 6.45352380 |
| 8 | neutral lipid catabolic process (GO:0046461) | 6.45352380 |
| 9 | valine metabolic process (GO:0006573) | 6.44989295 |
| 10 | fatty acid transmembrane transport (GO:1902001) | 5.90729104 |
| 11 | lipid particle organization (GO:0034389) | 5.78327863 |
| 12 | carnitine shuttle (GO:0006853) | 5.51112949 |
| 13 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.45857397 |
| 14 | positive regulation of fatty acid oxidation (GO:0046321) | 5.41251802 |
| 15 | triglyceride biosynthetic process (GO:0019432) | 5.19284177 |
| 16 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.18959897 |
| 17 | response to dietary excess (GO:0002021) | 5.15680048 |
| 18 | lipid storage (GO:0019915) | 5.04331430 |
| 19 | regulation of cholesterol storage (GO:0010885) | 5.04308474 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.98066141 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.97877429 |
| 22 | glycerolipid catabolic process (GO:0046503) | 4.96355728 |
| 23 | fatty acid beta-oxidation (GO:0006635) | 4.95682934 |
| 24 | neutral lipid biosynthetic process (GO:0046460) | 4.95373263 |
| 25 | acylglycerol biosynthetic process (GO:0046463) | 4.95373263 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.94504101 |
| 27 | negative regulation of protein autophosphorylation (GO:0031953) | 4.89120141 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.74928173 |
| 29 | negative regulation of granulocyte differentiation (GO:0030853) | 4.74230271 |
| 30 | negative regulation of cell killing (GO:0031342) | 4.72242603 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.72242603 |
| 32 | protein heterotrimerization (GO:0070208) | 4.64471471 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60464504 |
| 34 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.59469886 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 4.56554511 |
| 36 | response to type I interferon (GO:0034340) | 4.50175273 |
| 37 | type I interferon signaling pathway (GO:0060337) | 4.48924821 |
| 38 | cellular response to type I interferon (GO:0071357) | 4.48924821 |
| 39 | carnitine transmembrane transport (GO:1902603) | 4.32279785 |
| 40 | ovulation from ovarian follicle (GO:0001542) | 4.28335729 |
| 41 | branched-chain amino acid catabolic process (GO:0009083) | 4.26857468 |
| 42 | negative regulation of macrophage differentiation (GO:0045650) | 4.23869023 |
| 43 | sulfur amino acid catabolic process (GO:0000098) | 4.21265497 |
| 44 | fatty acid oxidation (GO:0019395) | 4.19757467 |
| 45 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.18868147 |
| 46 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.17970224 |
| 47 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.16419494 |
| 48 | lipid oxidation (GO:0034440) | 4.13409858 |
| 49 | fatty acid catabolic process (GO:0009062) | 4.08765078 |
| 50 | regulation of fatty acid oxidation (GO:0046320) | 4.07227302 |
| 51 | thioester biosynthetic process (GO:0035384) | 4.05773487 |
| 52 | acyl-CoA biosynthetic process (GO:0071616) | 4.05773487 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.95155547 |
| 54 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91582126 |
| 55 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.90414057 |
| 56 | carnitine transport (GO:0015879) | 3.86599347 |
| 57 | amino-acid betaine transport (GO:0015838) | 3.86599347 |
| 58 | cellular response to lithium ion (GO:0071285) | 3.86429378 |
| 59 | modulation by symbiont of host defense response (GO:0052031) | 3.85654080 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.85654080 |
| 61 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.85654080 |
| 62 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.85654080 |
| 63 | modulation by symbiont of host immune response (GO:0052553) | 3.85654080 |
| 64 | positive regulation by symbiont of host defense response (GO:0052509) | 3.85654080 |
| 65 | triglyceride metabolic process (GO:0006641) | 3.82440743 |
| 66 | positive regulation of glucose import (GO:0046326) | 3.79278678 |
| 67 | macrophage activation involved in immune response (GO:0002281) | 3.77920584 |
| 68 | fatty acid homeostasis (GO:0055089) | 3.76255952 |
| 69 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.75245318 |
| 70 | glycerol metabolic process (GO:0006071) | 3.74367409 |
| 71 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.72255810 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 3.70800916 |
| 73 | detection of other organism (GO:0098543) | 3.68639512 |
| 74 | positive regulation of glomerulus development (GO:0090193) | 3.66301755 |
| 75 | regulation of macrophage chemotaxis (GO:0010758) | 3.65208258 |
| 76 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.59328828 |
| 77 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.59076528 |
| 78 | negative regulation of interleukin-12 production (GO:0032695) | 3.58176591 |
| 79 | negative regulation of phagocytosis (GO:0050765) | 3.57742698 |
| 80 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.56397098 |
| 81 | negative regulation of lipid storage (GO:0010888) | 3.55758144 |
| 82 | coenzyme A biosynthetic process (GO:0015937) | 3.55130929 |
| 83 | acylglycerol metabolic process (GO:0006639) | 3.54945591 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.53820625 |
| 85 | acetyl-CoA metabolic process (GO:0006084) | 3.50413265 |
| 86 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.50314254 |
| 87 | neutral lipid metabolic process (GO:0006638) | 3.49409272 |
| 88 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.46836359 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.46815484 |
| 90 | L-serine transport (GO:0015825) | 3.45348331 |
| 91 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.44858673 |
| 92 | negative regulation of metanephros development (GO:0072217) | 3.42057248 |
| 93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41480615 |
| 94 | positive regulation of cholesterol efflux (GO:0010875) | 3.41316435 |
| 95 | cellular response to epinephrine stimulus (GO:0071872) | 3.41035887 |
| 96 | negative regulation of appetite (GO:0032099) | 3.40238567 |
| 97 | negative regulation of response to food (GO:0032096) | 3.40238567 |
| 98 | endocrine hormone secretion (GO:0060986) | 3.39890308 |
| 99 | detection of external biotic stimulus (GO:0098581) | 3.39867021 |
| 100 | intracellular lipid transport (GO:0032365) | 3.38940661 |
| 101 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.38812348 |
| 102 | plasma lipoprotein particle clearance (GO:0034381) | 3.38526737 |
| 103 | positive regulation of lipid storage (GO:0010884) | 3.36923968 |
| 104 | detection of bacterium (GO:0016045) | 3.36860832 |
| 105 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35747008 |
| 106 | regulation of interferon-alpha production (GO:0032647) | 3.30808769 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 3.29845413 |
| 108 | positive regulation of interferon-alpha production (GO:0032727) | 3.28730592 |
| 109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26410104 |
| 110 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.26219090 |
| 111 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.25954576 |
| 112 | oxaloacetate metabolic process (GO:0006107) | 3.25661873 |
| 113 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.23684043 |
| 114 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.23554912 |
| 115 | regulation of regulatory T cell differentiation (GO:0045589) | 3.20901350 |
| 116 | negative regulation of gluconeogenesis (GO:0045721) | 3.19483177 |
| 117 | positive regulation of sterol transport (GO:0032373) | 3.19356143 |
| 118 | positive regulation of cholesterol transport (GO:0032376) | 3.19356143 |
| 119 | regulation of gonadotropin secretion (GO:0032276) | 3.17684840 |
| 120 | T cell migration (GO:0072678) | 3.17151040 |
| 121 | regulation of tolerance induction (GO:0002643) | 3.17102282 |
| 122 | interferon-gamma production (GO:0032609) | 3.14714693 |
| 123 | alditol metabolic process (GO:0019400) | 3.14569329 |
| 124 | positive regulation of fat cell differentiation (GO:0045600) | 3.12098142 |
| 125 | positive regulation of glucose transport (GO:0010828) | 3.11660367 |
| 126 | positive regulation of steroid hormone secretion (GO:2000833) | 3.11359929 |
| 127 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.11137175 |
| 128 | response to folic acid (GO:0051593) | 3.10681198 |
| 129 | glomerular filtration (GO:0003094) | 3.10439909 |
| 130 | immunoglobulin mediated immune response (GO:0016064) | 3.09968386 |
| 131 | growth hormone receptor signaling pathway (GO:0060396) | 3.09445185 |
| 132 | microglial cell activation (GO:0001774) | 3.08912867 |
| 133 | negative T cell selection (GO:0043383) | 3.07627168 |
| 134 | regulation of lipid storage (GO:0010883) | 3.06847179 |
| 135 | negative thymic T cell selection (GO:0045060) | 3.06212021 |
| 136 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.05120287 |
| 137 | positive regulation of tolerance induction (GO:0002645) | 3.04755376 |
| 138 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04528565 |
| 139 | cellular extravasation (GO:0045123) | 3.03789837 |
| 140 | cellular response to ethanol (GO:0071361) | 3.03125609 |
| 141 | cellular lipid catabolic process (GO:0044242) | 3.03087964 |
| 142 | transcytosis (GO:0045056) | 3.03009271 |
| 143 | response to interleukin-15 (GO:0070672) | 3.00398531 |
| 144 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.00338396 |
| 145 | response to interferon-alpha (GO:0035455) | 2.98451157 |
| 146 | fat cell differentiation (GO:0045444) | 2.98117997 |
| 147 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.96891956 |
| 148 | quaternary ammonium group transport (GO:0015697) | 2.96253310 |
| 149 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.95369791 |
| 150 | response to peptidoglycan (GO:0032494) | 2.94452873 |
| 151 | detection of biotic stimulus (GO:0009595) | 2.91646892 |
| 152 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91586934 |
| 153 | neutrophil activation involved in immune response (GO:0002283) | 2.87263367 |
| 154 | response to host immune response (GO:0052572) | 2.86094029 |
| 155 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.86094029 |
| 156 | negative regulation of viral genome replication (GO:0045071) | 2.84423817 |
| 157 | germinal center formation (GO:0002467) | 2.82133295 |
| 158 | macrophage activation (GO:0042116) | 2.80705966 |
| 159 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79168700 |
| 160 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.78234319 |
| 161 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.76633074 |
| 162 | cellular response to interleukin-15 (GO:0071350) | 2.74709805 |
| 163 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.74438826 |
| 164 | defense response to protozoan (GO:0042832) | 2.74334509 |
| 165 | tolerance induction (GO:0002507) | 2.73668780 |
| 166 | positive regulation of type 2 immune response (GO:0002830) | 2.69262799 |
| 167 | T-helper 1 type immune response (GO:0042088) | 2.69261759 |
| 168 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67464168 |
| 169 | response to host (GO:0075136) | 2.66861400 |
| 170 | response to host defenses (GO:0052200) | 2.66861400 |
| 171 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.66861400 |
| 172 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66416777 |
| 173 | regulation of necroptotic process (GO:0060544) | 2.65975338 |
| 174 | B cell receptor signaling pathway (GO:0050853) | 2.65784521 |
| 175 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.65693674 |
| 176 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.65645319 |
| 177 | negative regulation of innate immune response (GO:0045824) | 2.64855569 |
| 178 | cellular response to interferon-gamma (GO:0071346) | 2.63762705 |
| 179 | response to interferon-beta (GO:0035456) | 2.63066902 |
| 180 | positive regulation of interferon-beta production (GO:0032728) | 2.62959406 |
| 181 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.62344162 |
| 182 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.61080524 |
| 183 | leukocyte aggregation (GO:0070486) | 2.60483487 |
| 184 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.59790110 |
| 185 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.59027847 |
| 186 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.58780687 |
| 187 | activated T cell proliferation (GO:0050798) | 2.58296454 |
| 188 | dendritic cell migration (GO:0036336) | 2.57106814 |
| 189 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.56876401 |
| 190 | defense response to virus (GO:0051607) | 2.55932207 |
| 191 | myeloid cell activation involved in immune response (GO:0002275) | 2.55189784 |
| 192 | positive regulation of antigen processing and presentation (GO:0002579) | 2.54899651 |
| 193 | positive thymic T cell selection (GO:0045059) | 2.54665211 |
| 194 | response to interferon-gamma (GO:0034341) | 2.53742568 |
| 195 | cellular response to exogenous dsRNA (GO:0071360) | 2.53419884 |
| 196 | response to protozoan (GO:0001562) | 2.53048405 |
| 197 | dendritic cell chemotaxis (GO:0002407) | 2.51938507 |
| 198 | positive T cell selection (GO:0043368) | 2.50385236 |
| 199 | regulation of antigen processing and presentation (GO:0002577) | 2.50292758 |
| 200 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.47305739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 6.36638446 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32756168 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.65491116 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.64586596 |
| 5 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.94147128 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.85771005 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.71848460 |
| 8 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.89939637 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89556997 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86601954 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.83516264 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81847098 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.74441907 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72749896 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58662675 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58403299 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.55512035 |
| 18 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.47241474 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38446155 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24411833 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.24194970 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.12314920 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08738694 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08308119 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05165653 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04486162 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 13.5754364 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97441333 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.96625257 |
| 30 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.94874271 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94181385 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91158619 |
| 33 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77666181 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73751896 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73021196 |
| 36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.64835496 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63974011 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.63722146 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62853589 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60328945 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58861129 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.58857136 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57951425 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.56635745 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.55870475 |
| 46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54781084 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49956065 |
| 48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.48876628 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44383979 |
| 50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.43429181 |
| 51 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.42919500 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34943494 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34252618 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33364712 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33276907 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33118847 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31072644 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28692303 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28519171 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26827940 |
| 61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23364444 |
| 62 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22771353 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22536791 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22405302 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22152525 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22147364 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.21388326 |
| 68 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18904996 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17722620 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15956283 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14068204 |
| 72 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13779307 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13548950 |
| 74 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10908527 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10083426 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09874485 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09057157 |
| 78 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07871519 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07871519 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05286461 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04068896 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02452136 |
| 83 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02416775 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02256544 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02150771 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00358561 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99346242 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99045236 |
| 89 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97486048 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97178365 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95854443 |
| 92 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95703191 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95609888 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95541197 |
| 95 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.94937278 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94453519 |
| 97 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94412887 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94192325 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93026059 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92435447 |
| 101 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91554801 |
| 102 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91340026 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90171631 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87801200 |
| 105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.87575660 |
| 106 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85754993 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85740409 |
| 108 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84777207 |
| 109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84031219 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83901228 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83698858 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82989987 |
| 113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82644238 |
| 114 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82618357 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82607026 |
| 116 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82489982 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82239159 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81964363 |
| 119 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.81770103 |
| 120 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80970261 |
| 121 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80803519 |
| 122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80627967 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.80523100 |
| 124 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79990860 |
| 125 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79923832 |
| 126 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79632438 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.79554877 |
| 128 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.79525114 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78400296 |
| 130 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77012588 |
| 131 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77012402 |
| 132 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76959890 |
| 133 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76562290 |
| 134 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76446142 |
| 135 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76446142 |
| 136 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.76425067 |
| 137 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76075436 |
| 138 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75722643 |
| 139 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.75138947 |
| 140 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.75138947 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74705672 |
| 142 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.74609419 |
| 143 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74097039 |
| 144 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73907435 |
| 145 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73721505 |
| 146 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73472594 |
| 147 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73465810 |
| 148 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73229794 |
| 149 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72761370 |
| 150 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72687452 |
| 151 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.72436258 |
| 152 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71835007 |
| 153 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.70612130 |
| 154 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.70337286 |
| 155 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69110811 |
| 156 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68208693 |
| 157 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67288800 |
| 158 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.67138885 |
| 159 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.64173495 |
| 160 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.62182413 |
| 161 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.61976524 |
| 162 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.60411588 |
| 163 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60341888 |
| 164 | GATA2_19941826_ChIP-Seq_K562_Human | 0.59259293 |
| 165 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.58797088 |
| 166 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58386140 |
| 167 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.57223507 |
| 168 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56842897 |
| 169 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.56471159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.37165131 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.37017886 |
| 3 | MP0004130_abnormal_muscle_cell | 4.97579690 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 4.51014840 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.31934698 |
| 6 | MP0005375_adipose_tissue_phenotype | 4.05235305 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.66686741 |
| 8 | MP0002876_abnormal_thyroid_physiology | 3.59966671 |
| 9 | MP0003303_peritoneal_inflammation | 3.24464063 |
| 10 | MP0002971_abnormal_brown_adipose | 3.15867942 |
| 11 | MP0000013_abnormal_adipose_tissue | 3.08393124 |
| 12 | MP0009115_abnormal_fat_cell | 2.97469353 |
| 13 | MP0003436_decreased_susceptibility_to | 2.95948737 |
| 14 | MP0006082_CNS_inflammation | 2.94425123 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.94126794 |
| 16 | MP0009785_altered_susceptibility_to | 2.92040764 |
| 17 | MP0005275_abnormal_skin_tensile | 2.91489809 |
| 18 | MP0000003_abnormal_adipose_tissue | 2.86965953 |
| 19 | MP0001790_abnormal_immune_system | 2.67415826 |
| 20 | MP0005387_immune_system_phenotype | 2.67415826 |
| 21 | MP0005671_abnormal_response_to | 2.65611375 |
| 22 | MP0001800_abnormal_humoral_immune | 2.63423409 |
| 23 | MP0005334_abnormal_fat_pad | 2.55241017 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.52984251 |
| 25 | MP0005025_abnormal_response_to | 2.49228234 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.44114558 |
| 27 | MP0002419_abnormal_innate_immunity | 2.37899781 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.35343449 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.34001536 |
| 30 | MP0002723_abnormal_immune_serum | 2.24668021 |
| 31 | MP0003763_abnormal_thymus_physiology | 2.23353026 |
| 32 | MP0002452_abnormal_antigen_presenting | 2.19991937 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 2.17070706 |
| 34 | MP0010155_abnormal_intestine_physiology | 2.13085309 |
| 35 | MP0002970_abnormal_white_adipose | 2.07732091 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 2.03356561 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.98614980 |
| 38 | MP0001819_abnormal_immune_cell | 1.98034544 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.97211916 |
| 40 | MP0003959_abnormal_lean_body | 1.92601470 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.81842486 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.80104673 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.74948398 |
| 44 | MP0005310_abnormal_salivary_gland | 1.74665317 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.74339659 |
| 46 | MP0004947_skin_inflammation | 1.69584701 |
| 47 | MP0009764_decreased_sensitivity_to | 1.68157144 |
| 48 | MP0002405_respiratory_system_inflammati | 1.65770656 |
| 49 | MP0005535_abnormal_body_temperature | 1.62759130 |
| 50 | MP0003195_calcinosis | 1.59935662 |
| 51 | MP0002009_preneoplasia | 1.58344883 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.52965248 |
| 53 | MP0000716_abnormal_immune_system | 1.51020357 |
| 54 | MP0003724_increased_susceptibility_to | 1.50786380 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.50603363 |
| 56 | MP0008469_abnormal_protein_level | 1.49165605 |
| 57 | MP0003866_abnormal_defecation | 1.48499557 |
| 58 | MP0003828_pulmonary_edema | 1.47125327 |
| 59 | MP0002060_abnormal_skin_morphology | 1.46661180 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.44263131 |
| 61 | MP0001661_extended_life_span | 1.41323031 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.40387235 |
| 63 | MP0005448_abnormal_energy_balance | 1.40106985 |
| 64 | MP0003186_abnormal_redox_activity | 1.39509285 |
| 65 | MP0002398_abnormal_bone_marrow | 1.39436397 |
| 66 | MP0003690_abnormal_glial_cell | 1.37646869 |
| 67 | MP0005451_abnormal_body_composition | 1.37075602 |
| 68 | MP0004272_abnormal_basement_membrane | 1.35499033 |
| 69 | MP0004883_abnormal_blood_vessel | 1.35461054 |
| 70 | MP0005452_abnormal_adipose_tissue | 1.34216539 |
| 71 | MP0001873_stomach_inflammation | 1.32269774 |
| 72 | MP0005360_urolithiasis | 1.31931422 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 1.29128739 |
| 74 | MP0000751_myopathy | 1.28712177 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 1.24269792 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.23243138 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.21098652 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.20976400 |
| 79 | MP0001851_eye_inflammation | 1.20360451 |
| 80 | MP0002796_impaired_skin_barrier | 1.19835856 |
| 81 | MP0001501_abnormal_sleep_pattern | 1.19385204 |
| 82 | MP0003045_fibrosis | 1.19089813 |
| 83 | MP0003252_abnormal_bile_duct | 1.18939111 |
| 84 | MP0004510_myositis | 1.15236427 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 1.14150721 |
| 86 | MP0002722_abnormal_immune_system | 1.13984497 |
| 87 | MP0003172_abnormal_lysosome_physiology | 1.13903793 |
| 88 | MP0005166_decreased_susceptibility_to | 1.13809522 |
| 89 | MP0001881_abnormal_mammary_gland | 1.12503587 |
| 90 | MP0009840_abnormal_foam_cell | 1.11666949 |
| 91 | MP0002429_abnormal_blood_cell | 1.10533509 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 1.08422901 |
| 93 | MP0006054_spinal_hemorrhage | 1.07716405 |
| 94 | MP0000604_amyloidosis | 1.07597688 |
| 95 | MP0008260_abnormal_autophagy | 1.05011593 |
| 96 | MP0008004_abnormal_stomach_pH | 1.04879075 |
| 97 | MP0000343_altered_response_to | 1.03116603 |
| 98 | MP0003448_altered_tumor_morphology | 1.03037014 |
| 99 | MP0000750_abnormal_muscle_regeneration | 1.02946235 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 1.02930658 |
| 101 | MP0003075_altered_response_to | 1.02739052 |
| 102 | MP0004147_increased_porphyrin_level | 1.00357607 |
| 103 | MP0003646_muscle_fatigue | 0.97531372 |
| 104 | MP0000609_abnormal_liver_physiology | 0.97269747 |
| 105 | MP0009763_increased_sensitivity_to | 0.97050090 |
| 106 | MP0005620_abnormal_muscle_contractility | 0.96806136 |
| 107 | MP0002006_tumorigenesis | 0.95976198 |
| 108 | MP0000759_abnormal_skeletal_muscle | 0.95818708 |
| 109 | MP0004381_abnormal_hair_follicle | 0.94610137 |
| 110 | MP0002933_joint_inflammation | 0.92315197 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.91113706 |
| 112 | MP0001663_abnormal_digestive_system | 0.91017803 |
| 113 | MP0000249_abnormal_blood_vessel | 0.90645841 |
| 114 | MP0006138_congestive_heart_failure | 0.89022820 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.87556995 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.87155226 |
| 117 | MP0001853_heart_inflammation | 0.85877428 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.85462459 |
| 119 | MP0004087_abnormal_muscle_fiber | 0.83993880 |
| 120 | MP0003091_abnormal_cell_migration | 0.83984889 |
| 121 | MP0003806_abnormal_nucleotide_metabolis | 0.81615736 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.81525072 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.80998876 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.80713197 |
| 125 | MP0005164_abnormal_response_to | 0.79896759 |
| 126 | MP0008775_abnormal_heart_ventricle | 0.78802424 |
| 127 | MP0003868_abnormal_feces_composition | 0.77102293 |
| 128 | MP0003948_abnormal_gas_homeostasis | 0.76113632 |
| 129 | MP0002254_reproductive_system_inflammat | 0.75091473 |
| 130 | MP0002132_abnormal_respiratory_system | 0.73514796 |
| 131 | MP0002909_abnormal_adrenal_gland | 0.73510609 |
| 132 | MP0005171_absent_coat_pigmentation | 0.73435904 |
| 133 | MP0002295_abnormal_pulmonary_circulatio | 0.73431872 |
| 134 | MP0003953_abnormal_hormone_level | 0.73035589 |
| 135 | MP0004134_abnormal_chest_morphology | 0.72997874 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.72474254 |
| 137 | MP0002638_abnormal_pupillary_reflex | 0.70227025 |
| 138 | MP0000749_muscle_degeneration | 0.69445337 |
| 139 | MP0009780_abnormal_chondrocyte_physiolo | 0.68777343 |
| 140 | MP0001764_abnormal_homeostasis | 0.65413608 |
| 141 | MP0005385_cardiovascular_system_phenoty | 0.63079344 |
| 142 | MP0001544_abnormal_cardiovascular_syste | 0.63079344 |
| 143 | MP0001756_abnormal_urination | 0.62628874 |
| 144 | MP0006036_abnormal_mitochondrial_physio | 0.62087626 |
| 145 | MP0005058_abnormal_lysosome_morphology | 0.60821676 |
| 146 | MP0005365_abnormal_bile_salt | 0.60302448 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.60168817 |
| 148 | MP0002168_other_aberrant_phenotype | 0.59730877 |
| 149 | MP0000681_abnormal_thyroid_gland | 0.58867142 |
| 150 | MP0000858_altered_metastatic_potential | 0.57959876 |
| 151 | MP0002249_abnormal_larynx_morphology | 0.56279314 |
| 152 | MP0005647_abnormal_sex_gland | 0.55166133 |
| 153 | MP0005330_cardiomyopathy | 0.54597203 |
| 154 | MP0003279_aneurysm | 0.53482170 |
| 155 | MP0001177_atelectasis | 0.53441383 |
| 156 | MP0000685_abnormal_immune_system | 0.53329061 |
| 157 | MP0005397_hematopoietic_system_phenotyp | 0.53063550 |
| 158 | MP0001545_abnormal_hematopoietic_system | 0.53063550 |
| 159 | MP0005319_abnormal_enzyme/_coenzyme | 0.52522071 |
| 160 | MP0000163_abnormal_cartilage_morphology | 0.52510436 |
| 161 | MP0002998_abnormal_bone_remodeling | 0.49739941 |
| 162 | MP0000627_abnormal_mammary_gland | 0.48359009 |
| 163 | MP0005369_muscle_phenotype | 0.48278375 |
| 164 | MP0002106_abnormal_muscle_physiology | 0.48110584 |
| 165 | MP0001533_abnormal_skeleton_physiology | 0.46289217 |
| 166 | MP0005388_respiratory_system_phenotype | 0.46022753 |
| 167 | MP0002133_abnormal_respiratory_system | 0.46022753 |
| 168 | MP0005076_abnormal_cell_differentiation | 0.45762442 |
| 169 | MP0001879_abnormal_lymphatic_vessel | 0.45675546 |
| 170 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.44269722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 8.77736847 |
| 2 | Acanthosis nigricans (HP:0000956) | 7.19472557 |
| 3 | Hypertriglyceridemia (HP:0002155) | 5.80599091 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.16057891 |
| 5 | Optic neuritis (HP:0100653) | 5.15147336 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.15147336 |
| 7 | Orchitis (HP:0100796) | 5.10143565 |
| 8 | Hyperglycinuria (HP:0003108) | 5.04215041 |
| 9 | Myositis (HP:0100614) | 4.93036528 |
| 10 | Difficulty running (HP:0009046) | 4.86105471 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.61457540 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 4.60424006 |
| 13 | Myoglobinuria (HP:0002913) | 4.55014776 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 4.54927503 |
| 15 | Long foot (HP:0001833) | 4.39446824 |
| 16 | Increased connective tissue (HP:0009025) | 4.35449590 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.30013108 |
| 18 | Growth hormone excess (HP:0000845) | 4.26038321 |
| 19 | Abnormality of T cell number (HP:0011839) | 4.24649569 |
| 20 | T lymphocytopenia (HP:0005403) | 4.16243341 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86265344 |
| 22 | Stomatitis (HP:0010280) | 3.82384715 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.81221158 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.80855485 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.78496815 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.75648660 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.70503971 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.65527535 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64183790 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.64183790 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.60910235 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57446825 |
| 33 | Vasculitis (HP:0002633) | 3.43000386 |
| 34 | Thyroid-stimulating hormone excess (HP:0002925) | 3.42675388 |
| 35 | Hemoptysis (HP:0002105) | 3.25905287 |
| 36 | Pigmentary retinal degeneration (HP:0001146) | 3.25048374 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.24837048 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.24837048 |
| 39 | Recurrent skin infections (HP:0001581) | 3.24794233 |
| 40 | Pulmonary infiltrates (HP:0002113) | 3.24643937 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24360281 |
| 42 | Gingivitis (HP:0000230) | 3.23135487 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 3.22330464 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 3.21670273 |
| 45 | Complement deficiency (HP:0004431) | 3.17332652 |
| 46 | Insulin resistance (HP:0000855) | 3.15797152 |
| 47 | Hydroxyprolinuria (HP:0003080) | 3.13638051 |
| 48 | Abnormality of proline metabolism (HP:0010907) | 3.13638051 |
| 49 | Facial diplegia (HP:0001349) | 3.11422003 |
| 50 | Spontaneous hematomas (HP:0007420) | 3.07800764 |
| 51 | Exercise-induced myalgia (HP:0003738) | 3.06032484 |
| 52 | Encephalitis (HP:0002383) | 3.05648626 |
| 53 | Hyperpituitarism (HP:0010514) | 3.05321279 |
| 54 | Meningitis (HP:0001287) | 3.03846655 |
| 55 | Recurrent viral infections (HP:0004429) | 2.98955568 |
| 56 | Recurrent bronchitis (HP:0002837) | 2.98772385 |
| 57 | Bone cyst (HP:0012062) | 2.98301556 |
| 58 | Hyperthyroidism (HP:0000836) | 2.96289905 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.94531750 |
| 60 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.93850790 |
| 61 | Subcapsular cataract (HP:0000523) | 2.91826907 |
| 62 | Neck muscle weakness (HP:0000467) | 2.90776425 |
| 63 | Arterial thrombosis (HP:0004420) | 2.89247711 |
| 64 | Muscle stiffness (HP:0003552) | 2.89122700 |
| 65 | Gingival bleeding (HP:0000225) | 2.88976766 |
| 66 | Spinal rigidity (HP:0003306) | 2.88392197 |
| 67 | Abnormality of T cells (HP:0002843) | 2.87493327 |
| 68 | Muscle fiber splitting (HP:0003555) | 2.86299543 |
| 69 | Muscle fiber inclusion bodies (HP:0100299) | 2.82417125 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.80916184 |
| 71 | Leukocytosis (HP:0001974) | 2.80405797 |
| 72 | Aortic dissection (HP:0002647) | 2.75685421 |
| 73 | Aortic aneurysm (HP:0004942) | 2.75595092 |
| 74 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73503726 |
| 75 | Ileus (HP:0002595) | 2.72620399 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.72133706 |
| 77 | Pulmonary embolism (HP:0002204) | 2.71757978 |
| 78 | Nemaline bodies (HP:0003798) | 2.68533242 |
| 79 | Chronic diarrhea (HP:0002028) | 2.68514482 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.67031008 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.65153947 |
| 82 | Malnutrition (HP:0004395) | 2.65122890 |
| 83 | Hematochezia (HP:0002573) | 2.65002455 |
| 84 | Peritonitis (HP:0002586) | 2.61011718 |
| 85 | Gangrene (HP:0100758) | 2.59321122 |
| 86 | Eosinophilia (HP:0001880) | 2.59181050 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.57241413 |
| 88 | Broad metatarsal (HP:0001783) | 2.55983552 |
| 89 | Pustule (HP:0200039) | 2.55970197 |
| 90 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54151315 |
| 91 | Accelerated skeletal maturation (HP:0005616) | 2.53311407 |
| 92 | Colitis (HP:0002583) | 2.52479607 |
| 93 | Follicular hyperkeratosis (HP:0007502) | 2.50272692 |
| 94 | Large hands (HP:0001176) | 2.49641986 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.48006774 |
| 96 | Inflammation of the large intestine (HP:0002037) | 2.46940833 |
| 97 | Pancreatitis (HP:0001733) | 2.46506471 |
| 98 | Myocardial infarction (HP:0001658) | 2.45813078 |
| 99 | Anorexia (HP:0002039) | 2.43319349 |
| 100 | Hypoalphalipoproteinemia (HP:0003233) | 2.43111806 |
| 101 | Lipoatrophy (HP:0100578) | 2.42662139 |
| 102 | Abnormality of complement system (HP:0005339) | 2.40107320 |
| 103 | Increased IgM level (HP:0003496) | 2.39198663 |
| 104 | Ketoacidosis (HP:0001993) | 2.38433335 |
| 105 | Abnormal hemoglobin (HP:0011902) | 2.36868280 |
| 106 | Chest pain (HP:0100749) | 2.36387722 |
| 107 | Granulocytopenia (HP:0001913) | 2.36124370 |
| 108 | Cerebral aneurysm (HP:0004944) | 2.35003707 |
| 109 | Testicular atrophy (HP:0000029) | 2.34981355 |
| 110 | Shawl scrotum (HP:0000049) | 2.34144486 |
| 111 | Chronic otitis media (HP:0000389) | 2.31125874 |
| 112 | Obstructive lung disease (HP:0006536) | 2.31068892 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31068892 |
| 114 | Urticaria (HP:0001025) | 2.29894369 |
| 115 | Epistaxis (HP:0000421) | 2.27744556 |
| 116 | Hypoglycemic coma (HP:0001325) | 2.27429984 |
| 117 | Congenital, generalized hypertrichosis (HP:0004540) | 2.27293959 |
| 118 | Proximal amyotrophy (HP:0007126) | 2.27080710 |
| 119 | Abnormality of eosinophils (HP:0001879) | 2.26599523 |
| 120 | Abnormality of the pleura (HP:0002103) | 2.25874218 |
| 121 | Stomach cancer (HP:0012126) | 2.25848510 |
| 122 | Prolonged bleeding time (HP:0003010) | 2.24417295 |
| 123 | Increased IgE level (HP:0003212) | 2.24374526 |
| 124 | Bulbar palsy (HP:0001283) | 2.23809501 |
| 125 | Increased cerebral lipofuscin (HP:0011813) | 2.22943895 |
| 126 | Gastrointestinal inflammation (HP:0004386) | 2.22061815 |
| 127 | Myotonia (HP:0002486) | 2.21814105 |
| 128 | Abnormality of T cell physiology (HP:0011840) | 2.20899402 |
| 129 | Abnormality of B cell number (HP:0010975) | 2.19911912 |
| 130 | Joint swelling (HP:0001386) | 2.19003062 |
| 131 | Dicarboxylic aciduria (HP:0003215) | 2.17639570 |
| 132 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17639570 |
| 133 | Prenatal maternal abnormality (HP:0002686) | 2.16981341 |
| 134 | Turricephaly (HP:0000262) | 2.16215952 |
| 135 | Glomerulonephritis (HP:0000099) | 2.13648467 |
| 136 | Prominent supraorbital ridges (HP:0000336) | 2.12248162 |
| 137 | Alopecia of scalp (HP:0002293) | 2.09238975 |
| 138 | Thyroiditis (HP:0100646) | 2.09106343 |
| 139 | Hyporeflexia of lower limbs (HP:0002600) | 2.08860554 |
| 140 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08645526 |
| 141 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08645526 |
| 142 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08645526 |
| 143 | Abnormality of the pericardium (HP:0001697) | 2.07862727 |
| 144 | Amyloidosis (HP:0011034) | 2.07233751 |
| 145 | Interstitial pulmonary disease (HP:0006530) | 2.07229052 |
| 146 | Hypergammaglobulinemia (HP:0010702) | 2.06702137 |
| 147 | Rectal prolapse (HP:0002035) | 2.06078994 |
| 148 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.05829573 |
| 149 | Acute hepatic failure (HP:0006554) | 2.05577337 |
| 150 | Gastrointestinal dysmotility (HP:0002579) | 2.04210925 |
| 151 | Slender build (HP:0001533) | 2.03113586 |
| 152 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02690747 |
| 153 | Flat acetabular roof (HP:0003180) | 2.00625892 |
| 154 | Ketosis (HP:0001946) | 1.99978305 |
| 155 | Scapular winging (HP:0003691) | 1.99442996 |
| 156 | Loss of speech (HP:0002371) | 1.99409705 |
| 157 | Duplicated collecting system (HP:0000081) | 1.99272341 |
| 158 | Nausea (HP:0002018) | 1.98823905 |
| 159 | Stridor (HP:0010307) | 1.98720156 |
| 160 | Alveolar cell carcinoma (HP:0006519) | 1.98088168 |
| 161 | Myopathic facies (HP:0002058) | 1.97201088 |
| 162 | Osteomyelitis (HP:0002754) | 1.97041522 |
| 163 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96895597 |
| 164 | Acne (HP:0001061) | 1.96580145 |
| 165 | Tetraparesis (HP:0002273) | 1.95972176 |
| 166 | Ankle contracture (HP:0006466) | 1.93177134 |
| 167 | Epidermoid cyst (HP:0200040) | 1.92932897 |
| 168 | Dysostosis multiplex (HP:0000943) | 1.92714733 |
| 169 | Panhypogammaglobulinemia (HP:0003139) | 1.92257875 |
| 170 | Vertigo (HP:0002321) | 1.92147722 |
| 171 | Episodic fever (HP:0001954) | 1.92102399 |
| 172 | Abnormality of the endocardium (HP:0004306) | 1.92076328 |
| 173 | Hypochromic anemia (HP:0001931) | 1.91816361 |
| 174 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.91557754 |
| 175 | Decreased subcutaneous fat (HP:0001002) | 1.91241267 |
| 176 | Fibular hypoplasia (HP:0003038) | 1.90477246 |
| 177 | Round ear (HP:0100830) | 1.89207278 |
| 178 | Toxemia of pregnancy (HP:0100603) | 1.88237675 |
| 179 | Increased CSF protein (HP:0002922) | 1.88167882 |
| 180 | Cellulitis (HP:0100658) | 1.87476181 |
| 181 | Glomerulopathy (HP:0100820) | 1.87060515 |
| 182 | Nephritis (HP:0000123) | 1.86987266 |
| 183 | Polyneuropathy (HP:0001271) | 1.86657305 |
| 184 | Thrombophlebitis (HP:0004418) | 1.86211934 |
| 185 | Neonatal hypoglycemia (HP:0001998) | 1.86060446 |
| 186 | Premature rupture of membranes (HP:0001788) | 1.84328060 |
| 187 | Gowers sign (HP:0003391) | 1.83162552 |
| 188 | Easy fatigability (HP:0003388) | 1.80993072 |
| 189 | Hypercortisolism (HP:0001578) | 1.77144608 |
| 190 | Abnormality of the axillary hair (HP:0100134) | 1.74664556 |
| 191 | Abnormality of secondary sexual hair (HP:0009888) | 1.74664556 |
| 192 | Abnormal eating behavior (HP:0100738) | 1.73628551 |
| 193 | Clitoromegaly (HP:0000057) | 1.73528064 |
| 194 | Hypoplastic ischia (HP:0003175) | 1.73516406 |
| 195 | Systemic lupus erythematosus (HP:0002725) | 1.71898467 |
| 196 | Hyperglycemia (HP:0003074) | 1.69582621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 5.29970690 |
| 2 | BCKDK | 3.81509631 |
| 3 | CAMK1G | 3.81501366 |
| 4 | TRIB3 | 3.78597785 |
| 5 | AKT3 | 3.57548757 |
| 6 | TYK2 | 3.48987027 |
| 7 | SIK1 | 3.46826146 |
| 8 | PIK3CA | 3.25771531 |
| 9 | RIPK4 | 2.97083289 |
| 10 | LMTK2 | 2.90003421 |
| 11 | MAP4K1 | 2.84696962 |
| 12 | TXK | 2.82262501 |
| 13 | BLK | 2.59905512 |
| 14 | IKBKE | 2.57296506 |
| 15 | MYLK | 2.53860621 |
| 16 | PDK2 | 2.50707171 |
| 17 | MAP3K6 | 2.32993762 |
| 18 | ACVR1B | 2.27331133 |
| 19 | MAP3K14 | 2.25219469 |
| 20 | DDR2 | 2.23745212 |
| 21 | EPHB2 | 2.17967359 |
| 22 | FGFR4 | 2.06920994 |
| 23 | MST1R | 2.05091131 |
| 24 | IRAK4 | 2.02091665 |
| 25 | OBSCN | 1.97231571 |
| 26 | PDK3 | 1.95291733 |
| 27 | PDK4 | 1.95291733 |
| 28 | INSRR | 1.76883817 |
| 29 | ZAP70 | 1.75744979 |
| 30 | IRAK3 | 1.75194308 |
| 31 | KIT | 1.74293713 |
| 32 | PRKAA2 | 1.72473215 |
| 33 | TBK1 | 1.60280440 |
| 34 | IRAK1 | 1.58624229 |
| 35 | PINK1 | 1.56552655 |
| 36 | BTK | 1.55289081 |
| 37 | MAPK15 | 1.50707856 |
| 38 | NLK | 1.49981994 |
| 39 | EPHB1 | 1.47890489 |
| 40 | EPHA3 | 1.45944969 |
| 41 | FES | 1.45418922 |
| 42 | SYK | 1.42804757 |
| 43 | BMPR2 | 1.39657379 |
| 44 | PHKG2 | 1.36888306 |
| 45 | PHKG1 | 1.36888306 |
| 46 | GRK7 | 1.35857789 |
| 47 | MAP3K13 | 1.35529652 |
| 48 | LATS1 | 1.34855618 |
| 49 | IKBKB | 1.33837324 |
| 50 | TEC | 1.32502130 |
| 51 | RIPK1 | 1.32422934 |
| 52 | ICK | 1.32376094 |
| 53 | ITK | 1.31782686 |
| 54 | TNK2 | 1.30493409 |
| 55 | GRK6 | 1.30121717 |
| 56 | PRKD2 | 1.28521405 |
| 57 | HCK | 1.24889812 |
| 58 | TTN | 1.24556247 |
| 59 | FRK | 1.24463657 |
| 60 | CDK6 | 1.24328582 |
| 61 | PDGFRA | 1.21346016 |
| 62 | LCK | 1.16199755 |
| 63 | LYN | 1.13532823 |
| 64 | TRPM7 | 1.13495471 |
| 65 | CDK9 | 1.09418113 |
| 66 | PIK3CG | 1.07858627 |
| 67 | TIE1 | 1.05995377 |
| 68 | MAP3K2 | 1.05765260 |
| 69 | CAMKK2 | 1.03961694 |
| 70 | PRKAA1 | 1.01732041 |
| 71 | CSK | 0.99412340 |
| 72 | MAP3K1 | 0.97693058 |
| 73 | GSK3A | 0.97204290 |
| 74 | BMX | 0.96351398 |
| 75 | FGFR3 | 0.93746579 |
| 76 | ADRBK2 | 0.87063580 |
| 77 | HIPK2 | 0.81893066 |
| 78 | CHUK | 0.77255735 |
| 79 | MARK3 | 0.74000289 |
| 80 | JAK1 | 0.71867671 |
| 81 | PRKCH | 0.71569689 |
| 82 | ERN1 | 0.71360515 |
| 83 | PDPK1 | 0.71253565 |
| 84 | MELK | 0.70944186 |
| 85 | PRKG2 | 0.69861787 |
| 86 | MAPK11 | 0.68655738 |
| 87 | YES1 | 0.68215391 |
| 88 | STK10 | 0.68022431 |
| 89 | MAP3K7 | 0.66463024 |
| 90 | DMPK | 0.64117745 |
| 91 | TAOK1 | 0.64054520 |
| 92 | MET | 0.63305851 |
| 93 | EIF2AK2 | 0.63151156 |
| 94 | FGFR2 | 0.62556113 |
| 95 | PAK2 | 0.62208852 |
| 96 | MAP2K6 | 0.61539994 |
| 97 | TAOK3 | 0.61530273 |
| 98 | SGK2 | 0.61527425 |
| 99 | TGFBR2 | 0.59029254 |
| 100 | PIM1 | 0.58475063 |
| 101 | FER | 0.58398609 |
| 102 | PRKCQ | 0.56527708 |
| 103 | FGR | 0.53745154 |
| 104 | MAP2K1 | 0.52839080 |
| 105 | STK24 | 0.52481698 |
| 106 | MARK2 | 0.52145185 |
| 107 | IRAK2 | 0.50601615 |
| 108 | PRKACG | 0.48851625 |
| 109 | STK38 | 0.48550856 |
| 110 | MAPK12 | 0.47934693 |
| 111 | RPS6KB1 | 0.46938604 |
| 112 | MTOR | 0.46673650 |
| 113 | JAK2 | 0.46408187 |
| 114 | STK3 | 0.46204128 |
| 115 | TAOK2 | 0.44509680 |
| 116 | PTK2B | 0.44042252 |
| 117 | PDGFRB | 0.43314646 |
| 118 | MATK | 0.42966327 |
| 119 | INSR | 0.41296021 |
| 120 | PIM2 | 0.40304535 |
| 121 | SIK3 | 0.39781932 |
| 122 | PDK1 | 0.39412379 |
| 123 | WNK1 | 0.39106575 |
| 124 | RET | 0.39069407 |
| 125 | RPS6KC1 | 0.38912663 |
| 126 | RPS6KL1 | 0.38912663 |
| 127 | LATS2 | 0.38898883 |
| 128 | NEK9 | 0.38476006 |
| 129 | MAP3K11 | 0.37575509 |
| 130 | JAK3 | 0.37357393 |
| 131 | PRKD1 | 0.37250320 |
| 132 | ADRBK1 | 0.36982681 |
| 133 | FYN | 0.36899109 |
| 134 | MAP3K5 | 0.36093690 |
| 135 | PRPF4B | 0.35669395 |
| 136 | IGF1R | 0.35651937 |
| 137 | EGFR | 0.35051739 |
| 138 | SGK3 | 0.34754249 |
| 139 | ABL2 | 0.34321681 |
| 140 | GRK5 | 0.33916725 |
| 141 | MAPK7 | 0.33265481 |
| 142 | ZAK | 0.32751932 |
| 143 | RPS6KA6 | 0.32647415 |
| 144 | CDC42BPA | 0.32310645 |
| 145 | FGFR1 | 0.31886001 |
| 146 | MAPK4 | 0.30651782 |
| 147 | MAP3K3 | 0.28588448 |
| 148 | CAMK1 | 0.28478041 |
| 149 | PRKD3 | 0.27219450 |
| 150 | MAPKAPK2 | 0.27069815 |
| 151 | SRC | 0.26830065 |
| 152 | CAMK2G | 0.25372708 |
| 153 | ABL1 | 0.25249883 |
| 154 | CSF1R | 0.24701592 |
| 155 | CAMK2D | 0.23779148 |
| 156 | MAPK3 | 0.23105508 |
| 157 | TTK | 0.23012041 |
| 158 | MAP2K3 | 0.22409059 |
| 159 | NEK6 | 0.21942785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.73309205 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.62751966 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.54865139 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.45633362 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.64845128 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.32789308 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.03272112 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.87803435 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59621263 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.57976771 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.57557491 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.50775792 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.42832558 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29720795 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26989425 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23941887 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.22193511 |
| 18 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.13764676 |
| 19 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.13502192 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01478338 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95811685 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.93277206 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88255600 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85115669 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.83257667 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.81493226 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80523874 |
| 28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73031517 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70685089 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.65425691 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.63377093 |
| 32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.60714895 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59340512 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58025775 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56784922 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.55736849 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50089286 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43194826 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42601852 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38151601 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33856529 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.33334469 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.33081188 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.32276636 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29836439 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29341235 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.28248161 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25457452 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25157214 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.24069501 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21363204 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19039989 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17632730 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 1.14620901 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11983950 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10888767 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 1.09065069 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08732989 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.08669358 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08332967 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08157806 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08080446 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06450071 |
| 64 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.04793018 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04220645 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00071037 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98809892 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.96229417 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95558467 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94808358 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94397185 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93031571 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92528742 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90569423 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89339692 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87834909 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87796642 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86916117 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.83880319 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.83376397 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83144440 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81239263 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80101468 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.78520159 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76227698 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75596262 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74832226 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72492386 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70593108 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69156855 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68225758 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67126495 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65814233 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.65534893 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65148407 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64231224 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64013619 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63529368 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.62286223 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61392597 |
| 101 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60218440 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.56977302 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.56073077 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55756752 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54049904 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50155793 |
| 107 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47787034 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46594142 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.45726855 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.44957044 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44719861 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44357796 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43811471 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43536474 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40452726 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39991699 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39125999 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37157625 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36884656 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36730510 |
| 121 | Lysosome_Homo sapiens_hsa04142 | 0.36610642 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35130208 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34804142 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34148406 |
| 125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33646767 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33569074 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.33076938 |
| 128 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32014307 |
| 129 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31484721 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31400019 |
| 131 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30269811 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29298185 |
| 133 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.27844334 |
| 134 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.27612632 |
| 135 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25340464 |
| 136 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25172226 |
| 137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.24813647 |
| 138 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24740674 |
| 139 | Lysine degradation_Homo sapiens_hsa00310 | 0.23832013 |
| 140 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.23704324 |
| 141 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23257054 |
| 142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.22982456 |
| 143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.22479215 |
| 144 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21673303 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19820940 |
| 146 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.18764351 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17902352 |
| 148 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17508118 |
| 149 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.17037287 |
| 150 | Melanoma_Homo sapiens_hsa05218 | 0.16394901 |
| 151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16086701 |
| 152 | Salivary secretion_Homo sapiens_hsa04970 | 0.15389389 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15126785 |
| 154 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13942317 |
| 155 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.13930601 |
| 156 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.13849137 |
| 157 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.13586856 |
| 158 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.12972189 |
| 159 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.12948542 |
| 160 | Alzheimers disease_Homo sapiens_hsa05010 | 0.12863089 |
| 161 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12450044 |
| 162 | Malaria_Homo sapiens_hsa05144 | 0.12426235 |
| 163 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11455359 |
| 164 | Parkinsons disease_Homo sapiens_hsa05012 | 0.11429898 |
| 165 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.10736185 |
| 166 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.09906075 |
| 167 | Amoebiasis_Homo sapiens_hsa05146 | 0.09899745 |
| 168 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.09851427 |

